HPQ vs STRO · P/E 8.6, rev $53.56B vs rev $62.0M
HP Inc (HPQ) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
HP Inc (HPQ) is a computer hardware company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported HPQ revenue for 2024-10-31 was $53.56B. Net income was $2.77B. Revenue was down 0.3% from 2023-10-31 to 2024-10-31. HPQ currently screens at market cap $21.20B and trailing P/E 8.6.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
HPQ currently screens at market cap $21.20B and trailing P/E 8.6. STRO currently screens at market cap $470.8M.
Not investment advice. Open the HPQ and STRO stock pages for the full models.
Not investment advice.